Can Histochemical c-mpl Positivity in Bone Marrow be a Predictor for Splenectomy in Immune Thrombocytopenia?
Irfan Yavasoglu, Nadide Gencer, Fulden Cantas, Firuzan Doger & Zahit Bolaman · International Blood Research & Reviews · 2019
Purpose: Splenectomy is used as the second line therapy in patients with immune thrombocytopenia (ITP). However, there is no parameter predicting splenectomy decision. Thrombopoietin is the main regulator of platelet count through its receptor c-mpl. The aim of the present study...
Open access
Research Article
10.9734/ibrr/2019/v9i430107